Objectives-Interactions between vascular cell adhesion molecule 1 and its ligand, the a4/01 integrin, have been shown to be important in a number of cellular events in vitro. To assess the importance of such interactions in the development of lymphocytic infiltration in diseased tissue the distribution of the two ligands has been studied immunohistochemically. Methods-Cryostat sections of labial tissue from patients with Sjogren's syndrome, normal labial tissues, rheumatoid synovia, and normal tonsils were stained using antibodies to VCAM-1, o4 and 01 integrin chains, and markers for T cells, B cells, macrophages, and follicular dendritic reticulum cells (FDRCs) 
been shown to be important in a number of cellular events in vitro. To assess the importance of such interactions in the development of lymphocytic infiltration in diseased tissue the distribution of the two ligands has been studied immunohistochemically. Methods-Cryostat sections of labial tissue from patients with Sjogren's syndrome, normal labial tissues, rheumatoid synovia, and normal tonsils were stained using antibodies to VCAM-1, o4 and 01 integrin chains, and markers for T cells, B cells, macrophages, and follicular dendritic reticulum cells (FDRCs), visualised using alkaline phosphatase and fast red. Results-Staining patterns for VCAM-1 and integrin chains in lymphocyte aggregates in synovial and labial tissues were similar. VCAM-1 staining was found on both vascular and ramifying dendritic cells at the centre of large T cell aggregates and in all aggregates where there was a central clustering of Most of the infiltrating cells in rheumatoid synovium were macrophages, despite the presence of well developed lymphocytic aggregates. In the labial tissue from patients with Sjogren's syndrome T cells predominated ( figure A, B In tonsils oA and 13 integrin staining was absent from, or only weakly present in, the central VCAM-1 rich areas of follicles.
Discussion
The role of integrins and their ligands in human inflammatory and autoimmune processes remains uncertain. Initially, VCAM-1 was chiefly implicated in the adherence of leucocytes to endothelium, but some studies suggest other possible roles, including the promotion of the proliferation and maturation of lymphocytes.'3"21 Direct evidence for the functional potential of adhesion molecules tends to come from in vitro studies, however. Immunohistochemical analysis plays an important complementary part in assessing the relevance of putative functional interactions to the whole tissue.
Dense lymphocyte aggregates can develop outside lymphoid tissues as part of a chronic inflammatory response, which also includes events such as vascular proliferation, fibrin deposition, and macrophage and polymorph infiltration. This is perhaps best seen in synovial tissue in rheumatoid arthritis. Similar lymphocyte aggregates also occur in the salivary glands of patients with Sjogren's syndrome in the absence of significant inflammation. In this situation there may be a specific disorder of lymphocyte traffic, possibly related to a low grade lymphoproliferative process.'0
The findings of this study indicate that large lymphocyte aggregates developing in nonlymphoid tissues, in either of the above contexts, mimic the development of lymphoid follicles in terms of the central accumulation of B cells and the presence of associated VCAM-1 and R4/23 positive cells. These latter cells are probably FDRCs, which, unlike other 'dendritic cells', are macrophage marker and class II negative. 30 The implication is that FDRCs can be differentiated from local perivascular fibroblastic cells in non-lymphoid tissues subject to chronic T cell infiltration. VCAM-1 expression within central areas of lymphocyte aggregates often extended beyond that of R4/23 and was often present where R4/23 was absent. This suggests that VCAM-1 expression appears on FRDCs or other supporting cells at an earlier stage of differentiation than R4/23, which is in keeping with ontological studies3' which suggest R4/23 is a 'late' FDRC marker. (Other markers of FDRCs which might clarify this are, unfortunately, unhelpful in a histological study such as this because they are also present on the adjacent B cell.) Although the factors responsible for T cell infiltration in chronic synovitis and in the labial tissue of patients with Sjogren's syndrome are thought to be different, it appears that the cellular patterns within lymphocyte aggregates follow the same rules. , .
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group.bmj.com on June 23, 2017 -Published by http://ard.bmj.com/ Downloaded from Despite the demonstration that VCAM-1 binding to the T cell surface of oA4/1 1 integrin can increase the adhesion of T cells to endothelial cells in vitro, it seems unlikely that VCAM-1 expression is important in T cell infiltration in the tissues studied. In samples where lymphocyte infiltrates were composed almost exclusively of T rather than B cells, VCAM-1 expression on the vessels was minimal.
In contrast, B cells were not seen at the centre of aggregates unless VCAM-1 positive cells were also present. There is evidence that in lymphoid tissues B cells migrate to the centre of follicles from the surrounding tissue through the outer T cell rich zone.32 In inflamed tissues, however, it seems possible that B cells appearing at the centre of aggregates have entered the tissue through VCAM-1 expressing venules at the centre of the aggregate. This difference from lymphoid tissue would not, perhaps, be surprising. In lymph nodes lymphocyte entry is thought to occur chiefly through the specialised high endothelial venules of the paracortical T cell areas. High endothelial venules are not present constitutively in synovium, but appear in rheumatoid arthritis vessels with similar properties, though only in areas rich in T cells.33 It seems reasonable to suggest that once T cells have accumulated in sufficient numbers to form substantial aggregates they induce VCAM-1 expression on cells in and around the walls of venules lying within the aggregates, and that the influx of B cells is then facilitated at this site.
The most unexpected finding of the study was the lack of correlation between the distribution of VCAM-1 expression and that of the integrin chains. This could suggest that the degree of expression of oA and 13 integrin chains on lymphocytes does not determine whether or not these cells associate with VCAM-1 positive cells, raising the question of the function of VCAM-1 expression at this site. The explanation may be complex and the lack of apparent codistribution of such adhesion ligands should perhaps not be too surprising.
The intensity of immunohistochemical staining will not necessarily reflect the functional activity of the molecule identified. VCAM-1 is expressed strongly on fibroblastic synoviocytes, where it may interact with integrin on the surface of the closely associated macrophages. The function of such an interaction is unknown. Thus it appears that a molecule initially implicated specifically in leucocyte/endothelial interactions has a number of roles in diseased non-lymphoid tissues which remain to be elucidated. 
